4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001013762-23-001303
Director acquired 342,980 shares (conversion)
- Director returned 342,980 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Sturge Simon · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-01 | Conversion : show line 1 in the form | +342,980 | 342,980 | D |
| 2023-10-01 | Returned to the company : show line 2 in the form | −342,980 | 0 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-01 | Conversion : show line 3 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG | −10,196 | 0 | D |
Loading xslF345X05/ownership.xml…